Ariad to Resume Marketing, Distributing Iclusig in U.S.

FDA allowing company to sell its leukemia drug under a more restricted label and with a risk-management protocol.



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304866904579270330201683824.html?mod=pls_whats_news_us_business_f

via IFTTT